Adaptation of Mindfulness Training to Treat Chronic Pain in the Military

July 30, 2018 updated by: RTI International
The overall aim of this study is to test the acceptability and feasibility of an interactive, web-based mindfulness training with active duty soldiers being treated for chronic pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The overall aim of study is to test the acceptability and feasibility of an interactive, web-based mindfulness training with active duty soldiers being treated for chronic pain. We will adapt the evidence-based Mindfulness-based Stress Reduction (MBSR) training for use with this population. The adapted training will be enhanced by mobile applications (apps) for skills practice, using an existing apps platform.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Fort Bragg, North Carolina, United States, 28301
        • Womack Army Medical Center at Ft. Bragg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients who have experienced chronic pain for at least 6 months

Exclusion Criteria:

  • Do not have any of the following conditions: substance abuse or dependence, psychosis, suicidal ideation in the last 2 months, high levels of trauma symptoms,
  • plans to have a permanent change of station or deploy in the coming 6 months, or
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness training
6 90-minute sessions interactive, web-based mindfulness training complemented with mobile application
interactive. web-based mindfulness training complemented with mobile application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Pain - Pain Intensity
Time Frame: Baseline
Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Intensity 3a
Baseline
Chronic Pain - Pain Intensity
Time Frame: 6 - 8 weeks post-treatment
Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Intensity 3a
6 - 8 weeks post-treatment
Chronic Pain - Pain Interference
Time Frame: Baseline
Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Interference 8a
Baseline
Chronic Pain - Pain Interference
Time Frame: 6 - 8 weeks post-treatment
Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Interference 8a
6 - 8 weeks post-treatment
Chronic Pain
Time Frame: Baseline
Assess intensity of sensory and affective pain using Short-Form McGill Pain Questionnaire
Baseline
Chronic Pain
Time Frame: 6 - 8 weeks post-treatment
Assess intensity of sensory and affective pain using Short-Form McGill Pain Questionnaire
6 - 8 weeks post-treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Co-Occurring Conditions - Depression
Time Frame: Baseline
Assess depression using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional Distress - Depression 8a
Baseline
Co-Occurring Conditions - Depression
Time Frame: 6 - 8 weeks post-treatment
Assess depression using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional Distress - Depression 8a
6 - 8 weeks post-treatment
Co-Occurring Conditions - Anxiety
Time Frame: Baseline
Assess anxiety using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0 - Emotional Distress- Anxiety 6a
Baseline
Co-Occurring Conditions - Anxiety
Time Frame: 6 - 8 weeks post-treatment
Assess anxiety using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0 - Emotional Distress- Anxiety 6a
6 - 8 weeks post-treatment
Co-Occurring Conditions - Alcohol Use
Time Frame: Baseline
Assess hazardous and harmful alcohol use and dependence using the Alcohol Use Disorders Identification Test (AUDIT)
Baseline
Co-Occurring Conditions - Alcohol Use
Time Frame: 6 - 8 weeks post-treatment
Assess hazardous and harmful alcohol use and dependence using the Alcohol Use Disorders Identification Test (AUDIT)
6 - 8 weeks post-treatment
Co-Occurring Conditions - Post Traumatic Stress Disorder
Time Frame: Baseline
Assess trauma symptoms in response to stressful experiences using the Post Traumatic Stress Disorder (PTSD) Checklist - Civilian version (PCL-C)
Baseline
Co-Occurring Conditions - Post Traumatic Stress Disorder
Time Frame: 6 - 8 weeks post-treatment
Assess trauma symptoms in response to stressful experiences using the Post Traumatic Stress Disorder (PTSD) Checklist - Civilian version (PCL-C)
6 - 8 weeks post-treatment
Co-Occurring Conditions - Prescription drug misuse
Time Frame: Baseline
Assess use of drugs not prescribed, or use of more than recommended dose, to feel good/get high/buzzed
Baseline
Co-Occurring Conditions - Prescription drug misuse
Time Frame: 6 - 8 weeks post-treatment
Assess use of drugs not prescribed, or use of more than recommended dose, to feel good/get high/buzzed
6 - 8 weeks post-treatment
Quality of Life - Physical Functioning
Time Frame: Baseline
Assess physical functioning using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Physical Function 12a
Baseline
Quality of Life - Physical Functioning
Time Frame: 6 - 8 weeks post-treatment
Assess physical functioning using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Physical Function 12a
6 - 8 weeks post-treatment
Quality of Life - Sleep disturbance
Time Frame: Baseline
Assess sleep quality, depth and restoration using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Sleep Disturbance 8a
Baseline
Quality of Life - Sleep disturbance
Time Frame: 6 - 8 weeks post-treatment
Assess sleep quality, depth and restoration using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Sleep Disturbance 8a
6 - 8 weeks post-treatment
Quality of Life - Fatigue
Time Frame: Baseline
Assess fatigue using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Fatigue 8a
Baseline
Quality of Life - Fatigue
Time Frame: 6 - 8 weeks post-treatment
Assess fatigue using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Fatigue 8a
6 - 8 weeks post-treatment
Quality of Life - Role satisfaction
Time Frame: Baseline
Assess social satisfaction using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Ability to Participate in Social Roles & Activities 8a
Baseline
Quality of Life - Role satisfaction
Time Frame: 6 - 8 weeks post-treatment
Assess social satisfaction using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Ability to Participate in Social Roles & Activities 8a
6 - 8 weeks post-treatment
Self-Regulation - Pain Catastrophizing Scale
Time Frame: Baseline
Assess experience of pain through sub-scales of rumination, magnification and helplessness
Baseline
Self-Regulation - Pain Catastrophizing Scale
Time Frame: 6 - 8 weeks post-treatment
Assess experience of pain through sub-scales of rumination, magnification and helplessness
6 - 8 weeks post-treatment
Self-Regulation - Chronic Pain Acceptance Scale
Time Frame: Baseline
Assess behavioral aspects of chronic pain acceptance
Baseline
Self-Regulation - Chronic Pain Acceptance Scale
Time Frame: 6 - 8 weeks post-treatment
Assess behavioral aspects of chronic pain acceptance
6 - 8 weeks post-treatment
Self-Regulation - Emotional Behavioral Dysregulation
Time Frame: Baseline
Assess emotional behavioral dysregulation using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional and Behavioral Dyscontrol
Baseline
Self-Regulation - Emotional Behavioral Dysregulation
Time Frame: 6 - 8 weeks post-treatment
Assess emotional behavioral dysregulation using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional and Behavioral Dyscontrol
6 - 8 weeks post-treatment
Mindfulness
Time Frame: Baseline
Assess mindfulness using the Five Factor Mindfulness Questionnaire (FFMQ)
Baseline
Mindfulness
Time Frame: 6 - 8 weeks post-treatment
Assess mindfulness using the Five Factor Mindfulness Questionnaire (FFMQ)
6 - 8 weeks post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shari Miller, PhD, RTI International

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2017

Primary Completion (Actual)

June 11, 2018

Study Completion (Actual)

June 11, 2018

Study Registration Dates

First Submitted

April 3, 2017

First Submitted That Met QC Criteria

April 3, 2017

First Posted (Actual)

April 7, 2017

Study Record Updates

Last Update Posted (Actual)

August 1, 2018

Last Update Submitted That Met QC Criteria

July 30, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R34AT008423-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Mindfulness Training

3
Subscribe